Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A usually malignant pancreatic neuroendocrine tumor producing vasoactive intestinal peptide (VIP). It may or may not be associated with inappropriate secretion of VIP and an associated clinical syndrome.
Biomarker and diagnostic research for pancreatic vasoactive intestinal peptide producing tumor has been reported in the published literature.
No clinical trials have been registered for pancreatic vasoactive intestinal peptide producing tumor.
17 publications have been identified in PubMed for pancreatic vasoactive intestinal peptide producing tumor. Research spans Case Report / Case Series (41%), Review / Meta-Analysis (35%), and Diagnostic / Biomarker (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 41% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 9:42 PM UTC
Research summaries |
6 |
35% |
Testing and diagnosis research | 1 | 6% |
Clinical study results | 1 | 6% |
Laboratory research | 1 | 6% |
New treatment approaches | 1 | 6% |
Helbing A (2026). [PMID: 29939520](https://pubmed.ncbi.nlm.nih.gov/29939520/). *Unknown Journal*. [Case Report / Case Series]
Lin L (2026). [PMID: 42008494](https://pubmed.ncbi.nlm.nih.gov/42008494/). *J Vis Exp*. [Case Report / Case Series]
Korleski J (2026). [PMID: 41498509](https://pubmed.ncbi.nlm.nih.gov/41498509/). *Endocr Relat Cancer*. [Diagnostic / Biomarker]
Wahab A (2025). [PMID: 40913783](https://pubmed.ncbi.nlm.nih.gov/40913783/). *Am J Case Rep*. [Case Report / Case Series]
Keretić D (2025). [PMID: 40941664](https://pubmed.ncbi.nlm.nih.gov/40941664/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Shekhda KM (2025). [PMID: 40384778](https://pubmed.ncbi.nlm.nih.gov/40384778/). *Endocr Oncol*. [Clinical Trial Publication]
Del Olmo-García M (2025). [PMID: 40647278](https://pubmed.ncbi.nlm.nih.gov/40647278/). *Nutrients*. [Review / Meta-Analysis]
van T Veld BR (2025). [PMID: 39954168](https://pubmed.ncbi.nlm.nih.gov/39954168/). *Endocr Pathol*. [Review / Meta-Analysis]
Gierach M (2025). [PMID: 41340353](https://pubmed.ncbi.nlm.nih.gov/41340353/). *Endokrynol Pol*. [Case Report / Case Series]
Wang W (2025). [PMID: 40482913](https://pubmed.ncbi.nlm.nih.gov/40482913/). *Cancer Lett*. [Basic Science / Preclinical]